Raymond James Financial
TDOC icon

Raymond James Financial’s Teladoc Health TDOC Stock Holding History

Raymond James Financial’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
28,714
-5,527
-16% -$36.8K ﹤0.01% 4942
2026
Q1 		$187K Sell
34,241
-3,921
-10% -$22K ﹤0.01% 4904
2025
Q4 		$267K Buy
38,162
+9,674
+34% +$75.7K ﹤0.01% 4648
2025
Q3 		$220K Sell
28,488
-9,916
-26% -$77.4K ﹤0.01% 4580
2025
Q2 		$334K Sell
38,404
-5,600
-13% -$40.6K ﹤0.01% 4238
2025
Q1 		$350K Buy
44,004
+11,694
+36% +$118K ﹤0.01% 4124
2024
Q4 		$294K Buy
+32,310
New +$312K ﹤0.01% 4192

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Raymond James Financial's TDOC Position: Q2 2026 in Review

Raymond James Financial reduced its Teladoc Health (TDOC) stake by 16% in Q2 2026, selling an estimated $36.8K and leaving 28,714 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #4942.

Raymond James Financial first reported a position in TDOC in Q4 2024 and has held it in 7 quarters since. The position peaked at $350K in Q1 2025. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Raymond James Financial held 28,714 shares of Teladoc Health worth $243K as of Q2 2026.
  • Raymond James Financial sold 5,527 Teladoc Health shares in Q2 2026, an estimated $36.8K.
  • Teladoc Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4942 holding.
  • Raymond James Financial first reported a position in Teladoc Health in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Teladoc Health position peaked at $350K in Q1 2025.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.